GRP
CPRX

Global Retirement Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Global Retirement Partners’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
+10,845
New +$320K 0.01% 1239
2025
Q4 		$4.48K Buy
192
+59
+44% +$1.31K ﹤0.01% 3472
2025
Q3 		$2.62K Sell
133
-890
-87% -$18.3K ﹤0.01% 3222
2025
Q2 		$22.2K Buy
+1,023
New +$24.1K ﹤0.01% 2237
2024
Q4 		$3.78K Buy
181
+8
+5% +$172 ﹤0.01% 2820
2024
Q3 		$3.44K Sell
173
-548
-76% -$10.2K ﹤0.01% 2729
2024
Q2 		$11.2K Buy
721
+651
+930% +$10.1K ﹤0.01% 2272
2024
Q1 		$1.12K Sell
70
-104
-60% -$1.57K ﹤0.01% 2949
2023
Q4 		$2.5K Buy
174
+101
+138% +$1.38K ﹤0.01% 2590
2023
Q3 		$883 Buy
73
+21
+40% +$281 ﹤0.01% 2804
2023
Q2 		$699 Sell
52
-1
-2% -$14 ﹤0.01% 2868
2023
Q1 		$880 Buy
+53
New +$874 ﹤0.01% 2773

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Retirement Partners's CPRX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 10,845 shares worth $341K. The stake represents 0.01% of the portfolio and ranks #1239 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CPRX as recently as Q4 2025.

Global Retirement Partners first reported a position in CPRX in Q1 2023 and has held it in 12 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Global Retirement Partners held 10,845 shares of Catalyst Pharmaceutical worth $341K as of Q2 2026.
  • Catalyst Pharmaceutical was a new Global Retirement Partners position in Q2 2026.
  • Catalyst Pharmaceutical made up 0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1239 holding.
  • Global Retirement Partners first reported a position in Catalyst Pharmaceutical in Q1 2023 and has held it in 12 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.